AAAAAA
Results:
1-22
|
Results: 22
Authors:
SEGALL MD
PAYNE MC
ELLIS SW
TUCKER GT
BOYES RN
Citation: Md. Segall et al., FIRST PRINCIPLES CALCULATION OF THE ACTIVITY OF CYTOCHROME-P450, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 57(4), 1998, pp. 4618-4621
Authors:
SEGALL MD
PAYNE MC
ELLIS SW
TUCKER GT
BOYES RN
Citation: Md. Segall et al., AN AB-INITIO APPROACH TO THE UNDERSTANDING OF CYTOCHROME-P450 LIGAND INTERACTIONS, Xenobiotica, 28(1), 1998, pp. 15-20
Authors:
ELLIS SW
Citation: Sw. Ellis, SITE-DIRECTED - MUTAGENESIS OF PUTATIVE ACTIVE-SITE RESIDUES OF CYP2D6, British Journal of Pharmacology, 123, 1998, pp. 357-357
Authors:
SEGALL MD
PAYNE MC
ELLIS SW
TUCKER GT
BOYES RN
Citation: Md. Segall et al., AB-INITIO MOLECULAR MODELING IN THE STUDY OF DRUG-METABOLISM, European journal of drug metabolism and pharmacokinetics, 22(4), 1997, pp. 283-289
Authors:
GHAHRAMANI P
ELLIS SW
LENNARD MS
RAMSAY LE
TUCKER GT
Citation: P. Ghahramani et al., CYTOCHROMES P450 MEDIATING THE N-DEMETHYLATION OF AMITRIPTYLINE, British journal of clinical pharmacology, 43(2), 1997, pp. 137-144
Authors:
MARSH JCW
ELLIS SW
CHOWDRY J
PARRYJONES N
GORDONSMITH EC
TUCKER GT
Citation: Jcw. Marsh et al., CYTOCHROMES P45-2D6 AND 2E1 MUTATIONS ARE NOT ASSOCIATED WITH AN INCREASED RISK OF IDIOSYNCRATIC APLASTIC-ANEMIA, Experimental hematology, 25(8), 1997, pp. 608-608
Authors:
LIN LY
DISTEFANO EW
SCHMITZ DA
HSU L
ELLIS SW
LENNARD MS
TUCKER GT
CHO AK
Citation: Ly. Lin et al., OXIDATION OF METHAMPHETAMINE AND METHYLENEDIOXYMETHAMPHETAMINE BY CYP2D6, Drug metabolism and disposition, 25(9), 1997, pp. 1059-1064
Authors:
LENNARD MS
CREWE HK
ELLIS SW
TUCKER GT
Citation: Ms. Lennard et al., THE 4-HYDROXYLATION OF TAMOXIFEN BY HUMAN LIVER CYTOCHROMES P450 2D6,2C9 AND 3A4, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 37-37
Authors:
CREWE HK
ELLIS SW
LENNARD MS
TUCKER GT
Citation: Hk. Crewe et al., VARIABLE CONTRIBUTION OF CYTOCHROMES P450 2D6, 2C9 AND 3A4 TO THE 4-HYDROXYLATION OF TAMOXIFEN BY HUMAN LIVER-MICROSOMES, Biochemical pharmacology, 53(2), 1997, pp. 171-178
Authors:
ELLIS SW
GEYER JR
Citation: Sw. Ellis et Jr. Geyer, PREVALENCE OF COMPLEMENTARY THERAPIES AMONG PEDIATRIC CANCER-PATIENTS, Journal of investigative medicine, 44(1), 1996, pp. 98-98
VARIABLE CONTRIBUTION OF CYP2D6 TO THE N-DEALKYLATION OF S-(-)-PROPRANOLOL BY HUMAN LIVER-MICROSOMES
Authors:
ROWLAND K
ELLIS SW
LENNARD MS
TUCKER GT
Citation: K. Rowland et al., VARIABLE CONTRIBUTION OF CYP2D6 TO THE N-DEALKYLATION OF S-(-)-PROPRANOLOL BY HUMAN LIVER-MICROSOMES, British journal of clinical pharmacology, 42(3), 1996, pp. 390-393
Authors:
ELLIS SW
ROWLAND K
ACKLAND MJ
REKKA E
SIMULA AP
LENNARD MS
WOLF CR
TUCKER GT
Citation: Sw. Ellis et al., INFLUENCE OF AMINO-ACID RESIDUE-374 OF CYTOCHROME-P-450 2D6 (CYP2D6) ON THE REGIO-SELECTIVE AND ENANTIO-SELECTIVE METABOLISM OF METOPROLOL, Biochemical journal, 316, 1996, pp. 647-654
Authors:
BERESFORD AP
TAYLOR RJ
ASHCROFT JA
AYRTON J
TUCKER GT
ELLIS SW
Citation: Ap. Beresford et al., EXPRESSION OF HUMAN CYTOCHROME P4501A1 (CYP1A1) IN SACCHAROMYCES-CEREVISIAE INHIBITS CELL-DIVISION, Xenobiotica, 26(10), 1996, pp. 1013-1023
Authors:
COLEMAN T
ELLIS SW
MARTIN IJ
LENNARD MS
TUCKER GT
Citation: T. Coleman et al., 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IS N-DEMETHYLATEDBY CYTOCHROMES P450 2D6, 1A2 AND 3A4 - IMPLICATIONS FOR SUSCEPTIBILITY TO PARKINSONS-DISEASE, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 685-690
Authors:
COLEMAN T
ELLIS SW
MARTIN IJ
LENNARD MS
TUCKER GT
Citation: T. Coleman et al., MPTP IS N-DEMETHYLATED BY CYPS 2D6, 1A2 AND 3A4 - IMPLICATIONS FOR SUSCEPTIBILITY TO PARKINSONS-DISEASE, British Journal of Pharmacology, 117, 1996, pp. 127-127
Authors:
MACKMAN R
TSCHIRRETGUTH RA
SMITH G
HAYHURST GP
ELLIS SW
LENNARD RS
TUCKER GT
WOLF CR
DEMONTELLANO PRO
Citation: R. Mackman et al., ACTIVE-SITE TOPOLOGIES OF HUMAN CYP2D6 AND ITS ASPARTATE-301-]GLUTAMATE, ASPARAGINE, AND GLYCINE MUTANTS, Archives of biochemistry and biophysics, 331(1), 1996, pp. 134-140
Authors:
ELLIS SW
HAYHURST GP
SMITH G
LIGHTFOOT T
WONG MMS
SIMULA AP
ACKLAND MJ
STERNBERG MJE
LENNARD MS
TUCKER GT
WOLF CR
Citation: Sw. Ellis et al., EVIDENCE THAT ASPARTIC-ACID-301 IS A CRITICAL SUBSTRATE-CONTACT RESIDUE IN THE ACTIVE-SITE OF CYTOCHROME-P450 2D6, The Journal of biological chemistry, 270(49), 1995, pp. 29055-29058
Authors:
CHING MS
BLAKE CL
GHABRIAL H
ELLIS SW
LENNARD MS
TUCKER GT
SMALLWOOD RA
Citation: Ms. Ching et al., POTENT INHIBITION OF YEAST-EXPRESSED CYP2D6 BY DIHYDROQUINIDINE, QUINIDINE, AND ITS METABOLITES, Biochemical pharmacology, 50(6), 1995, pp. 833-837
Authors:
BULSARA D
ACKLAND MJ
DUNCAN JN
REES SA
ELLIS SW
LENNARD MS
TUCKER GT
Citation: D. Bulsara et al., EVALUATION OF A TEMPLATE MODEL OF THE CYP2D6 ACTIVE-SITE BY EXPERIMENTAL TESTING OF COMPOUNDS WITH RECOMBINANT HUMAN CYP2D6, The FASEB journal, 8(7), 1994, pp. 10001244-10001244
Authors:
ROWLAND K
YEO WW
ELLIS SW
CHADWICK IG
HAQ I
LENNARD MS
JACKSON PR
RAMSAY LE
TUCKER GT
Citation: K. Rowland et al., INHIBITION OF CYP2D6 ACTIVITY BY TREATMENT WITH PROPRANOLOL AND THE ROLE OF 4-HYDROXY PROPRANOLOL, British journal of clinical pharmacology, 38(1), 1994, pp. 9-14
REGIOSELECTIVE AND ENANTIOSELECTIVE METABOLISM OF METOPROLOL BY 2 HUMAN CDNA-DERIVED CYP2D6 PROTEINS
Authors:
ELLIS SW
ROWLAND K
HARLOW JR
SIMULA AP
LENNARD MS
WOODS HF
TUCKER GT
WOLF CR
Citation: Sw. Ellis et al., REGIOSELECTIVE AND ENANTIOSELECTIVE METABOLISM OF METOPROLOL BY 2 HUMAN CDNA-DERIVED CYP2D6 PROTEINS, British Journal of Pharmacology, 112, 1994, pp. 210000124-210000124
Authors:
TUCKER GT
LENNARD MS
ELLIS SW
WOODS HF
CHO AK
LIN LY
HIRATSUKA A
SCHMITZ DA
CHU TYY
Citation: Gt. Tucker et al., THE DEMETHYLENATION OF METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) BY DEBRISOQUINE HYDROXYLASE (CYP2D6), Biochemical pharmacology, 47(7), 1994, pp. 1151-1156
Risultati:
1-22
|